|Articles|May 3, 2017
George Clinical Acquires Vector Oncology
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division.
Advertisement
George Clinical, a full-service CRO in the Asia-Pacific region, has acquired Memphis-based Vector Oncology's Pharma Services Division. This acquisition aims to assist George Clinical in providing oncology trial delivery solutions throughout the Asia-Pacific region.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
ACT Brief: AI-Enabled End-to-End Trials, New Phase III Data in HIV, and a First-Line Shift in HER2-Positive Breast Cancer
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5